首页/数据集/Assessment of bias-profile in published trials on MTX efficacy in psoriasis1.

Assessment of bias-profile in published trials on MTX efficacy in psoriasis1.

Figshare2016-05-13 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Assessment_of_bias-profile_in_published_trials_on_MTX_efficacy_in_psoriasis_sup_1_sup_/3379759 数据链接链接失效反馈

官方服务：

资源简介：

Assessment of bias-profile in published trials on MTX efficacy in psoriasis1.

应用场景：

创建时间：

2016-05-13

临床试验偏倚评估

Cochrane工具应用

Risk of bias for the randomised clinical trials according to the Cochrane tool.

NIAID Data Ecosystem120

银屑病药物疗效

真实世界研究

This record contains raw data related to article “Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian la

Zenodo2022-11-08 更新40

Supplementary Material for: Blinding assessments in neonatal ventilation meta-analyses: a systematic meta-epidemiological review

新生儿机械通气荟萃分析

临床试验偏倚评估

Introduction: Randomization and blinding are generally important in randomised trials. In neonatology, blinding of ventilation strategies is unfeasible if not impossible and we hypothesized that its i

Figshare2024-05-06 更新40

Assessment of Risk of Bias in Randomized Controlled Trial in Key Question #2 (Treatment).

临床试验偏倚评估

随机对照试验质量

aSee Supplementary Information S6 for item descriptions. Items are scored as ‘high’, ‘low’, or ‘uncertain’ risk of bias.

Figshare2015-12-02 更新60

Supplemental material,"Ixekizumab’s early effectiveness is altered by metabolic syndrome in patients with psoriasis: a 12-week, single-center, retrospective study"

银屑病药物疗效

代谢综合征与疗效关联

Supplemental Table 2. The comparison of the rate of PASI 75, PASI 90 and PASI 100 in different baseline metabolic syndrome status by GEE models.GEE, generalized estimating equation; MetS, metabolic sy

NIAID Data Ecosystem40

Assessment of bias-profile in published trials on MTX efficacy in psoriasis1.

资源简介：

相关数据集